All reported giving is concentrated in three very large grants listed only as “See Statement 17,” so the foundation’s public grant record here points to a single, undisclosed recipient or set of recipients rather than a diversified portfolio. Because the actual beneficiary(ies) and purposes are not shown, it is not possible to reliably describe issue-specific priorities from this data alone. The pattern suggests the foundation uses large, targeted awards (or pass-through funding) documented elsewhere in company filings.
Highly concentrated: three very large grants all directed to the same undisclosed recipient(s) (repeat grantee entry). Appears to favor large, possibly multi-million-dollar one-off or few-time commitments rather than many small grants.
Boehringer Ingelheim Cares Foundation Inc’s public grant record is dominated by three exceptionally large awards, each listed only as “See Statement 17.” The largest reported grant is $1,590,692,397 in 2025, followed by $1,292,546,623 in 2024 and $1,031,033,999 in 2023. That pattern points to highly concentrated giving rather than a broad portfolio of many smaller awards. The foundation’s stated programs clarify the kinds of support it can provide. Its Financial Contribution Program supports nonprofit organizations working to improve access to health care and to enhance math and science education for underserved populations. Its Product Donations Program donates essential medicines and related services through partnerships with relief organizations and public health partners, serving patients in need domestically and internationally. Other active programs include employee volunteer efforts and a Patient Assistance Program that provides select medicines free of charge to eligible uninsured and underinsured patients in the U.S. Across the available record, the foundation’s giving is organized around health access, medicines, and education support, with public grant details tied to a corporate reporting structure rather than named open-market grantees.
Health care access appears in the foundation’s formal contribution program, which supports nonprofit organizations working to improve access to health care. The same program also supports math and science education for underserved populations, linking health-focused philanthropy with STEM access. Medicine access is another clear theme. Through the Product Donations Program, the foundation donates essential medicines and related services to patients in need domestically and internationally, working through relief organizations and public health partners such as AmeriCares, Direct Relief International, and MAP International. Patient-level support is also part of the model. The Patient Assistance Program provides select medicines free of charge to eligible uninsured and underinsured patients in the U.S., indicating a direct-services channel alongside organizational grants and product donations. Volunteerism is present as well through an employee volunteer program that supports company-sponsored and individual community projects.
$1.6B
$251.9M
$1.7B
$1.6B
Most grants fall between $1.2B and $1.4B, with a median of $1.3B.
25th Percentile
$1.2B
Median
$1.3B
75th Percentile
$1.4B
About 100% of grants go to recipients in CT.
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Notable grantees: See Statement 17
The reported grant-size distribution is extremely large and tightly clustered: p25 is $1,161,790,311, median is $1,292,546,623, and p75 is $1,441,619,510. The top three grants all fall in the billions, which shows a concentrated pattern of major awards rather than many smaller checks. The record also suggests repetition across years. The same unnamed recipient label, “See Statement 17,” appears for the 2025, 2024, and 2023 grants, indicating a recurring reporting pattern or a continuing commitment documented through corporate filings. The foundation is a regular funder and does not make program-related investments. Unsolicited applications are not accepted in the listed programs.
All reported grants in the available record go to recipients in the United States, with 100% of grants tied to the HQ state, Connecticut. The recipient city is not identified in the grant list, which instead records each award in CT under “See Statement 17.” The foundation’s active programs also show a U.S. footprint, with the Financial Contribution Program and Patient Assistance Program focused domestically, while the Product Donations Program reaches both the United States and global partners.
Its listed programs center on health care access, essential medicines, STEM education for underserved populations, employee volunteerism, and patient assistance. The Financial Contribution Program, Product Donations Program, Employee Volunteer Program, and Patient Assistance Program each point to a health- and community-oriented funding model.
No. The listed Financial Contribution Program, Product Donations Program, and Patient Assistance Program all state that they do not accept unsolicited requests.
The grant record is dominated by very large awards: the 25th percentile is $1,161,790,311, the median is $1,292,546,623, and the 75th percentile is $1,441,619,510. That pattern indicates highly concentrated funding at a very large scale.
Yes. Every reported grant in the available record goes to the United States, and 100% are tied to Connecticut, the foundation’s top state by grant count.
The same recipient label, “See Statement 17,” appears in the 2025, 2024, and 2023 top grants. That suggests a repeated or continuing commitment documented through the foundation’s filings.
2025
Source: IRS Form 990-PF, fiscal year 2025.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| See Statement 17 | NA, CT | $1,590,692,397 | 2025 | N/A |
| See Statement 17 | NA, CT | $1,292,546,623 | 2024 | N/A |
| See Statement 17 | NA, CT | $1,031,033,999 | 2023 | N/A |
See Statement 17
$1,590,692,397N/A
See Statement 17
$1,292,546,623N/A
See Statement 17
$1,031,033,999N/A